MM

Matthew Matt Callahan

Mr Callahan is a life sciences executive based in Philadelphia and a founder of Botanix. He has been the founding CEO or Executive Director of a number of ASX listed and private pharmaceutical and health tech companies, including iCeutica Inc, Churchill Pharmaceuticals LLC, Dimerix Biosciences Ltd, Orthocell Ltd, Respirion Pharmaceuticals Pty Ltd, Rumin8 Pty Ltd and Emyria Ltd. Mr Callahan has led the development and commercialization of several products that have received FDA and other global regulatory approvals, he has more than 25 years of industry, IP and legal experience.

Holdings

Company
Last Notice
Direct Shares
Indirect Shares
Options
Convertibles
BOT
BOT
30/06/24N/A74,586,791N/AN/A
OCC
OCC
30/06/22N/A1,229,6222,000,000N/A

Transactions

Company
Date
Type
Amount
Price
Value
Notes
BOT
BOT
02/12/24
Issued
3,000,000$0.350$1,050,000Issue of securities
BOT
BOT
18/05/23
Exercise
1,166,667$0.085$99,166Conversion of securities
BOT
BOT
18/05/23
Buy
1,166,667$0.085$99,166Conversion of securities
BOT
BOT
20/03/23
Exercise
1,166,666$0.097$113,166Conversion of securities
BOT
BOT
20/03/23
Buy
1,166,666$0.097$113,166Conversion of securities